Bulletin
Investor Alert

Company Close Updates Archives | Email alerts

Dec. 7, 2020, 5:06 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock falls Monday, underperforms market

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP shed 3.52% to $1.37 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.45% to 12,519.95 and the Dow Jones Industrial Average DJIA falling 0.49% to 30,069.79. Corbus Pharmaceuticals Holdings Inc. closed $8.41 short of its 52-week high ($9.78), which the company achieved on August 31st.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Fate Therapeutics Inc. FATE rose 37.80% to $83.77, Vanda Pharmaceuticals Inc. VNDA fell 0.75% to $13.25, and Viking Therapeutics Inc. VKTX fell 3.95% to $6.08. Trading volume (4.1 M) remained 593,620 below its 50-day average volume of 4.7 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.